GLP-1–MK-801

N/A

Report date: 2026/04/08 20:02:35
NME

Base Information

Drug NameGLP-1–MK-801
Drug Alias NameGLP-1–MK-801
ClassificationSmall molecules > Synthetic peptide > Peptide drug conjugate (PDC)
Mechanisms of ActionGlucagon-like peptide 1 receptor agonistsGlutamate [NMDA] receptor antagonists
TargetsGlucagon-like peptide 1 receptorGlutamate [NMDA] receptor
Therapy Area/IndicationsObesity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryDenmark
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesThe Novo Nordisk Foundation Center For Basic Metabolic Research
China Registration ClassN/A

Develop Information

Active CompaniesThe Novo Nordisk Foundation Center For Basic Metabolic Research
Inactive CompaniesN/A
Active IndicationsObesity
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A